Detailed Narrative
Robust Domestic Growth Offsets International Headwinds
Rainbow reported a strong 18.5% YoY revenue growth for Q3 FY25, reaching ₹398 crores. This was underpinned by a 12% increase in both inpatient and outpatient volumes. While the international business segment saw a sharp 40% decline due to geopolitical instability in regions like Bangladesh and Somalia, the domestic business remained resilient. Management has revised the FY25 international revenue target down to ₹34 crores from ₹44 crores last year, but remains optimistic about long-term medical tourism potential once new markets like the Philippines and Uganda are explored.
Aggressive Capacity Expansion Roadmap
The company is on track to add approximately 1,000 beds over the next 3.5 years. In FY26 alone, Rainbow plans to add 250 beds across three new hospitals, which are expected to be asset-light leased facilities with a capex of ₹60-65 lakh per bed. The Rajahmundry hub (100 beds) is nearing completion for a May 2025 launch, while spoke hospitals in Electronic City and Hennur are slated for Q2 FY26. This expansion is expected to drive a 12.5% to 13% capacity increase in the next financial year.
Strategic Shift in NCR: The Gurugram Project
Rainbow is transitioning to an asset-heavy model for its entry into the Delhi-NCR region. The Gurugram project involves two land parcels in Sectors 56 and 44, with construction expected to start in 4-6 weeks. The company has already invested ₹180-190 crores in land and expects to spend another ₹400 crores over the next three years. This results in a significantly higher capex of ₹1.5 crores per bed, which management justifies as necessary for a state-of-the-art super-specialty facility aimed at serving North India and international patients.
Operational Metrics: Focus on ARPP over ARPOB
Management highlighted a shift in internal focus from ARPOB to Average Revenue Per Patient (ARPP) due to the volatility of Average Length of Stay (ALOS). ALOS increased by 12% this quarter, partly due to insurance approval delays and higher case complexity, which naturally suppresses ARPOB. ARPP has shown consistent growth of 5% to 8%, reflecting better pricing power and a shift toward more complex clinical cases. Mature hospitals continue to maintain healthy occupancy levels above 60%, with a theoretical peak identified at 68-70%.
Margin Resilience Amidst Expansion Drag
Despite the inherent drag from three new hospitals launched in early 2024, Rainbow maintained a strong EBITDA margin of 33.8% in Q3. The EBITDA drag from new units was approximately ₹8-9 crores for the first nine months of FY25. Management guided for a stable EBITDA margin band within +/- 1% of the current 32.7% level as they balance the ramp-up of existing new units with the initial costs of upcoming facilities. One-off📎 expenses of ₹7 crores related to silver jubilee celebrations also impacted 9M margins slightly.